Novartis


 Novartis Heart Failure Drug faces European Setbacks

Novartis Heart Failure Drug faces European Setbacks

European regulators have dealt a setback to a novel heart failure drug under development by Novartis. The European Medicines Ag...

Jan 28 2014, 5:30am CST